Proposing a Phase Model for 360° VR Journalism: Resources and Challenges of Production

The emergence of 360° technology and marketable virtual reality (VR) glasses has enabled 360° VR journalism to develop unique storytelling possibilities and to generate heightened levels of immersion and empathy for the audience. Nevertheless, the technology and therefore the journalistic output have difficulties in reaching a larger market of users. Exploring possible reasons for this, the article provides insights into seven guided interviews with journalists experienced in the production of 360° VR content in Germany. Based on these insights, it proposes a production phase model and considers the resources of time, personnel and technology, the special features of storytelling, the new job description of 360° VR journalists, and the dependence of these aspects on the current situation of 360° VR journalism. It thereby provides both inspiration for further research and practical points of reference for journalists

Intracarotid administration of human bone marrow mononuclear cells in rat photothrombotic ischemia

Background: Increasing evidence suggests that cell therapy improves functional recovery in experimental models of stroke and myocardial infarction. So far only small pilot trials tested the effects of cell therapy in stroke patients, whereas large clinical trials were conducted in patients with ischemic heart disease. To investigate the therapeutic benefit of cell therapy to improve the recovery after stroke, we determined the efficacy of bone marrow derived mononuclear cells, which were shown to improve the recovery in experimental and clinical acute myocardial infarction studies, in a rat stroke model. Methods: Adult male Wistar rats were randomly assigned to receive either five million human bone marrow mononuclear cells (hBMC) or placebo intraarterially 3 days after photothrombotic ischemia. For immunosuppression the animals received daily injections of cyclosporine throughout the experiment, commencing 24 hours before the cell transplantation. A battery of behavioural tests was performed before and up to 4 weeks after ischemia. Results: Body temperature and body weight revealed no difference between groups. Neurological deficits measured by the Rotarod test, the adhesive-removal test and the cylinder test were not improved by hBMC transplantation compared to placebo. Conclusions: This study demonstrates that hBMC do not improve functional recovery when transplanted intraaterially 3 days after the onset of focal cerebral ischemia. A possible reason for the failed neurological improvement after cell therapy might be the delayed treatment initiation compared to other experimental stroke studies that showed efficacy of bone marrow mononuclear cells

Headache and spontaneous glabellar ecchymosis: More than a self-injury behavior?

A33-YEAR-OLD MAN PRESENTED to our outpatient clinic for evaluation of severe headaches located at the left eye and forehead and multiple episodes of discoloration of the superior glabella. The pain was described as throbbing lasting for 30–45 min about 2–3 times per month with minimal nausea, photophobia, left eye tearing, redness, and ptosis. The erythema-like lesion developed after a severe headache episode and gradually resolved over the next few days. The patient disclosed habitually rubbing the forehead or face during pain episodes, making an ‘artificial’ post-traumatic skin ecchymosis unlikely

Erythropoietin for stroke treatment: dead or alive?

Endothelial progenitor cell (EPC) mobilization from the bone marrow was considered to improve outcome after ischemic stroke. Erythropoietin (EPO) might be a potential candidate stroke drug that increases the number of circulating EPCs. In the previous issue of Critical Care, Yip and colleagues investigated the effect of EPO in stroke patients on both clinical outcome and EPC stimulation. Although beneficial effects of EPO were observed, several issues regarding EPO's suitability as a stroke drug remain

Bismarckturm und Totenburg : Machtsymbole im Schaffen von Wilhelm Kreis

Wissenschaftliches Kolloquium vom 18. bis 21. Juni 1992 in Weimar an der Hochschule für Architektur und Bauwesen zum Thema: ‚Architektur und Macht

A high-altitude peatland record of environmental changes in the NW Argentine Andes (24 ° S) over the last 2100 years

High-altitude cushion peatlands are versatile archives for high-resolution palaeoenvironmental studies, due to their high accumulation rates, range of proxies, and sensitivity to climatic and/or human-induced changes. Especially within the Central Andes, the knowledge about climate conditions during the Holocene is limited. In this study, we present the environmental and climatic history for the last 2100 years of Cerro Tuzgle peatland (CTP), located in the dry Puna of NW Argentina, based on a multi-proxy approach. X-ray fluorescence (XRF), stable isotope and element content analyses (δ13C, δ15N, TN and TOC) were conducted to analyse the inorganic geochemistry throughout the sequence, revealing changes in the peatlands' past redox conditions. Pollen assemblages give an insight into substantial environmental changes on a regional scale. The palaeoclimate varied significantly during the last 2100 years. The results reflect prominent late Holocene climate anomalies and provide evidence that in situ moisture changes were coupled to the migration of the Intertropical Convergence Zone (ITCZ). A period of sustained dry conditions prevailed from around 150 BC to around AD 150. A more humid phase dominated between AD 200 and AD 550. Afterwards, the climate was characterised by changes between drier and wetter conditions, with droughts at around AD 650-800 and AD 1000-1100. Volcanic forcing at the beginning of the 19th century (1815 Tambora eruption) seems to have had an impact on climatic settings in the Central Andes. In the past, the peatland recovered from climatic perturbations. Today, CTP is heavily degraded by human interventions, and the peat deposit is becoming increasingly susceptible to erosion and incision.Fil: Schittek, Karsten. University of Heidelberg; Alemania. Universitat Zu Köln; AlemaniaFil: Kock, Sebastian T.. University of Heidelberg; Alemania. Research Center Jülich; AlemaniaFil: Lücke, Andreas. Helmholtz Gemeinschaft. Forschungszentrum Jülich; AlemaniaFil: Hense, Jonathan. Universitaet Bonn; AlemaniaFil: Ohlendorf, Christian. Universitat Bremen; AlemaniaFil: Kulemeyer, Julio José. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia de Jujuy. Universidad Nacional de Jujuy. Centro de Investigaciones y Transferencia de Jujuy; ArgentinaFil: Lupo, Liliana Concepcion. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Investigaciones y Transferencia de Jujuy. Universidad Nacional de Jujuy. Centro de Investigaciones y Transferencia de Jujuy; ArgentinaFil: Schäbitz, Frank. Universitat Zu Köln; Alemani

The hematopoietic factor GM-CSF (Granulocyte-macrophage colony-stimulating factor) promotes neuronal differentiation of adult neural stem cells in vitro

BACKGROUND: Granulocyte-macrophage colony stimulating factor (GM-CSF) is a hematopoietic growth factor involved in the generation of granulocytes, macrophages, and dendritic cells from hematopoietic progenitor cells. We have recently demonstrated that GM-CSF has anti-apoptotic functions on neurons, and is neuroprotective in animal stroke models. RESULTS: The GM-CSF receptor α is expressed on adult neural stem cells in the rodent brain, and in culture. Addition of GM-CSF to NSCs in vitro increased neuronal differentiation in a dose-dependent manner as determined by quantitative PCR, reporter gene assays, and FACS analysis. CONCLUSION: Similar to the hematopoietic factor Granulocyte-colony stimulating factor (G-CSF), GM-CSF stimulates neuronal differentiation of adult NSCs. These data highlight the astonishingly similar functions of major hematopoietic factors in the brain, and raise the clinical attractiveness of GM-CSF as a novel drug for neurological disorders